Humana

Humana, a leading health and well-being company, operates Humana Ventures as its corporate venture capital arm. Established in 2007, this strategic investment vehicle plays a crucial role in advancing Humana's mission to help members achieve their best health. Unlike traditional VCs, Humana Ventures' primary objective is not purely financial return but rather to identify, invest in, and partner with innovative companies that align with Humana's strategic priorities and enhance its core business capabilities.

The investment focus of Humana Ventures is broad within the healthcare ecosystem, targeting early to growth-stage companies that are developing solutions in areas such as digital health, value-based care, health equity, care delivery innovation, and consumer engagement. They seek technologies and services that can improve health outcomes, enhance member experience, and drive efficiency across the healthcare continuum. Humana Ventures often acts as a strategic co-investor, collaborating with traditional venture capital firms and other corporate VCs to support promising startups.

Over the years, Humana Ventures has built a diverse portfolio of companies, demonstrating its commitment to fostering innovation. For instance, the firm participated in DispatchHealth's $200 million Series D funding round in 2021, a testament to its willingness to support high-growth companies transforming care delivery. Their portfolio includes notable names like Omada Health, Heal, and Accolade (which later went public), showcasing their impact on the digital health landscape. Their investments are designed to create synergistic relationships, allowing Humana to integrate cutting-edge solutions into its offerings while providing portfolio companies with access to Humana's vast market reach and expertise.